RPL17 and hepatocellular carcinoma: VEGF also regulates immunity in hepatocellular carcinoma by inducing the expression of immunosuppressive receptors, including PD-1, lymphocyte activation gene 3, T-cell immunoglobulin and mucin domain 3 (82), promoting CD8+ T-cell failure and tumor escape free escape (Figure 3).